Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion

Cell Death and Disease

Volumn 6, Issue 2, 2015, Pages

  Morle A ^a,b   Garrido, C ^a,b,c   Micheau, O ^a,b,c  

^a Institut Médical de Génétique et d Immunologie   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEATH RECEPTOR; FLICE INHIBITORY PROTEIN; GLYCEROL; LYSINE; THREONINE; CFLAR PROTEIN, MOUSE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER THERAPY; CELL DEATH; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; MITOCHONDRION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UBIQUITINATION; DRUG EFFECTS; GENETICS; IMMUNOPRECIPITATION; METABOLISM; THERMOTHERAPY; TUMOR CELL LINE;

APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE, TUMOR; CYTOSOL; HUMANS; HYPERTHERMIA, INDUCED; IMMUNOPRECIPITATION; POINT MUTATION; RECEPTORS, DEATH DOMAIN; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84927643207     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.12     Document Type: Article

References (53)

1. Yang A, Wilson NS, Ashkenazi A. Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation. Curr Opin Cell Biol 2010; 22: 837-844.
2. Micheau O, Shirley S, Dufour F. Death receptors as targets in cancer. Br J Pharmacol 2013; 169: 1723-1744.
3. McLornan DP, Barrett HL, Cummins R, McDermott U, McDowell C, Conlon SJ et al. Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancer. Clin Cancer Res 2010; 16: 3442-3451.
4. McLornan D, Hay J, McLaughlin K, Holohan C, Burnett AK, Hills RK et al. Prognostic and therapeutic relevance of c-FLIP in acutemyeloid leukaemia. Br J Haematol 2013; 160: 188-198.
5. Riley JS, Hutchinson R, McArt DG, Crawford N, Holohan C, Paul I et al. Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer. Cell Death Dis 2013; 4: e951.
6. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190-195.
7. Shirley S, Micheau O. Targeting c-FLIP in cancer. Cancer Lett 2013; 332: 141-150.
8. Ueffing N, Keil E, Freund C, Kuhne R, Schulze-Osthoff K, Schmitz I. Mutational analyses of c-FLIPR, the only murine short FLIP isoform, reveal requirements for DISC recruitment. Cell Death Differ 2008; 15: 773-782.
9. Lavrik IN, Krammer PH. Regulation of CD95/Fas signaling at the DISC. Cell Death Differ 2012; 19: 36-41.
10. Salon C, Eymin B, Micheau O, Chaperot L, Plumas J, Brambilla C et al. E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short). Cell Death Differ 2006; 13: 260-272.
11. Ricci MS, Jin Z, Dews M, Yu D, Thomas-Tikhonenko A, Dicker DT et al. Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity. Mol Cell Biol 2004; 24: 8541-8555.
12. Kreuz S, Siegmund D, Scheurich P, Wajant H. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 2001; 21: 3964-3973.
13. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 2001; 21: 5299-5305.
14. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114: 181-190.
15. Travert M, Ame-Thomas P, Pangault C, Morizot A, Micheau O, Semana G et al. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL. J Immunol 2008; 181: 1001-1011.
16. Braun FK, Hirsch B, Al-Yacoub N, Durkop H, Assaf C, Kadin ME et al. Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP. J Invest Dermatol 2010; 130: 826-840.
17. Song X, Kim SY, Zhou Z, Lagasse E, Kwon YT, Lee YJ. Hyperthermia enhances mapatumumab-induced apoptotic death through ubiquitin-mediated degradation of cellular FLIP(long) in human colon cancer cells. Cell Death Dis 2013; 4: e577.
18. Wilkie-Grantham RP, Matsuzawa S, Reed JC. Novel phosphorylation and ubiquitination sites regulate reactive oxygen species-dependent degradation of anti-apoptotic c-FLIP protein. J Biol Chem 2013; 288: 12777-12790.
19. Kaunisto A, Kochin V, Asaoka T, Mikhailov A, Poukkula M, Meinander A et al. PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability. Cell Death Differ 2009; 16: 1215-1226.
20. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006; 124: 601-613.
21. Kundu M, Pathak SK, Kumawat K, Basu S, Chatterjee G, Pathak S et al. ATNF-and c-Cbldependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosisinduced macrophage apoptosis. Nat Immunol 2009; 10: 918-926.
22. Panner A, Crane CA, Weng C, Feletti A, Parsa AT, Pieper RO. A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res 2009; 69: 7911-7916.
23. Moulin M, Dumontet C, Arrigo AP. Sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis by hyperthermia. Cancer Lett 2007; 250: 117-127.
24. Moulin M, Arrigo AP. Caspases activation in hyperthermia-induced stimulation of TRAIL apoptosis. Cell Stress Chaperones 2008; 13: 313-326.
25. Moulin M, Arrigo AP. Long lasting heat shock stimulation of TRAIL-induced apoptosis in transformed T lymphocytes. Exp Cell Res 2006; 312: 1765-1784.
26. Moulin M, Carpentier S, Levade T, Arrigo AP. Potential roles of membrane fluidity and ceramide in hyperthermia and alcohol stimulation of TRAIL apoptosis. Apoptosis 2007; 12: 1703-1720.
27. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000; 2: 645-652.
28. Panner A, Murray JC, Berger MS, Pieper RO. Heat shock protein 90alpha recruits FLIPS to the death-inducing signaling complex and contributes to TRAIL resistance in human glioma. Cancer Res 2007; 67: 9482-9489.
29. Lewis J, Devin A, Miller A, Lin Y, Rodriguez Y, Neckers L et al. Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem 2000; 275: 10519-10526.
30. Song X, Kim SY, Lee YJ. Evidence for two modes of synergistic induction of apoptosis by mapatumumab and oxaliplatin in combination with hyperthermia in human colon cancer cells. PLoS One 2013; 8: e73654.
31. Dickens LS, Boyd RS, Jukes-Jones R, Hughes MA, Robinson GL, Fairall L et al. A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol Cell 2012; 47: 291-305.
32. Majkut J, Sgobba M, Holohan C, Crawford N, Logan AE, Kerr E et al. Differential affinity of FLIP and procaspase 8 for FADD's DED binding surfaces regulates DISC assembly. Nat Comm 2014; 5: 3350.
33. Maeda T, Fuchimoto S, Orita K. Hyperthermic enhancement of the antitumor effect of natural human tumor necrosis factor-alpha and-beta: an in vitro and in vivo study. Jpn J Cancer Res 1988; 79: 1054-1061.
34. Tomasovic SP, Barta M, Klostergaard J. Temporal dependence of hyperthermic augmentation of macrophage-TNF production and tumor cell-TNF sensitization. Int J Hyperthermia 1989; 5: 625-639.
35. Bonvalot S, Rimareix F, Causeret S, Le Pechoux C, Boulet B, Terrier P et al. Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1mg and melphalan (T1-M HILP) is safe and efficient. Ann Surg Oncol 2009; 16: 3350-3357.
36. Bonvalot S, de Baere T, Mendiboure J, Paci A, Farace F, Drouard-Troalen L et al. Hyperthermic pelvic perfusion with tumor necrosis factor-alpha for locally advanced cancers: encouraging results of a phase II study. Ann Surg 2012; 255: 281-286.
37. Hermisson M, Wagenknecht B, Wolburg H, Glaser T, Dichgans J, Weller M. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release. Oncogene 2000; 19: 2338-2345.
38. Tran SE, Meinander A, Holmstrom TH, Rivero-Muller A, Heiskanen KM, Linnau EK et al. Heat stress downregulates FLIP and sensitizes cells to Fas receptor-mediated apoptosis. Cell Death Differ 2003; 10: 1137-1147.
39. Yuen WF, Fung KP, Lee CY, Choy YM, Kong SK, Ko S et al. Hyperthermia and tumour necrosis factor-alpha induced apoptosis via mitochondrial damage. Life Sci 2000; 67: 725-732.
40. Klostergaard J, Leroux ME, Auzenne E, Khodadadian M, Spohn W, Wu JY et al. Hyperthermia engages the intrinsic apoptotic pathway by enhancing upstream caspase activation to overcome apoptotic resistance in MCF-7 breast adenocarcinoma cells. J Cell Biochem 2006; 98: 356-369.
41. Ko S, Yuen WF, Fung KP, Lee CY, Choy YM, Cheng HK et al. Reversal of TNF-alpha resistance by hyperthermia: role of mitochondria. Life Sci 2000; 67: 3113-3121.
42. Bockbrader KM, Tan M, Sun Y. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL-and etoposide-induced apoptosis in breast cancer cells. Oncogene 2005; 24: 7381-7388.
43. Ehenrenschwender M, Bittner S, Seibold K, Wajant H. XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis. Cell Death Dis 2014; 5: e1570.
44. Algeciras-Schimnich A, Griffith TS, Lynch DH, Paya CV. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J Immunol 1999; 162: 5205-5211.
45. Wang J, Lobito AA, Shen F, Hornung F, Winoto A, Lenardo MJ. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur J Immunol 2000; 30: 155-163.
46. Micheau O. Cellular FLICE-inhibitory protein: an attractive therapeutic target? Expert Opin Ther Targets 2003; 7: 559-573.
47. Fukazawa T, Fujiwara T, Uno F, Teraishi F, Kadowaki Y, Itoshima T et al. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene 2001; 20: 5225-5231.
48. Rosenberg B, Kemeny G, Switzer RC, Hamilton TC. Quantitative evidence for protein denaturation as the cause of thermal death. Nature 1971; 232: 471-473.
49. Dubois MF, Hovanessian AG, Bensaude O. Heat-shock-induced denaturation of proteins. Characterization of the insolubilization of the interferon-induced p68 kinase. J Biol Chem 1991; 266: 9707-9711.
50. Schleich K, Warnken U, Fricker N, Ozturk S, Richter P, Kammerer K et al. Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. Mol Cell 2012; 47: 306-319.
51. Ku T, Lu P, Chan C, Wang T, Lai S, Lyu P et al. Predicting melting temperature directly from protein sequences. Comput Biol Chem 2009; 33: 445-450.
52. Schneider P. Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins. Methods Enzymol 2000; 322: 325-345.
53. Morizot A, Merino D, Lalaoui N, Jacquemin G, Granci V, Iessi E et al. Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level. Cell Death Differ 2011; 18: 700-711.